This invention relates to morpholine derivatives of formula (I) and their use as antagonists of orexin receptors.

 
Web www.patentalert.com

< Target for treating athersclerosis, obesity and type II diabetes

< Transgenic expression from a SOCS-3 promoter in vertebrate cells

> Quinolinone derivatives and uses thereof

> Polycyclic guanine derivative phosphodiesterase V inhibitors
~ 00207